InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: None

Wednesday, 02/09/2022 6:11:52 PM

Wednesday, February 09, 2022 6:11:52 PM

Post# of 16699
Someone has opined often in the past to do an 'inside' paper deal with the BTH IP to our 'sister'.*. This would clean up the IP for them and get operating $ for AGN.
Yost still stole BTH work when he slid to Owlstone. Sucks but BTH couldn't produce a product. ie>NASH>AGN...
Irrelevant?

IPF/CC may hit a couple end-points...
Currently strong support in the UK with top of the line folks involved in the microdose DMT clinical trial. It could progress fast. Maybe...
Cancer research is often for 'possible' terminal patients. There is funding support and continuous research efforts for solutions, especially in the USA.

Seems we've possibly passed the lows after consolidation and folks may look ahead. A fair+ Risk to Reward, IMO.

...GLTA...

* 5M shares @ $.5. Bonuses to BODs included.